Q3 2007 Cytokinetics Inc. Earnings Conference Call – Final.
The News Review:
- Q3 2007 Cytokinetics Inc. Earnings Conference Call – Final.
- IVR Clinical Concepts and mniComm Systems Inc. Announce Co-Marketing…
- California-Based CR pens peration in Morrisville
- Q3 2007 Kforce Inc. Earnings Conference Call – Final.
- Indian student develops molecular condom
- Mice help chlamydia vaccine research
- rthopedic firms reveal payments in settlement
Q3 2007 Cytokinetics Inc. Earnings Conference Call – Final.
Free with registration – Fair Disclosure Wire – AccessMyLibrary.com – Oct 31, 2007
Moreover we believe these continuing investments in research and development provide greater value to our shareholders going forward. To provide greater detail on our ongoing clinical development activities I would now like to turn the call over to Andy Wolff our Chief Medical fficer. ANDREW WLFF SVP F CLINICAL RESEARCH AND DEVELPMENT CM CYTKINETICS INC. : Thank you Robert. Within each of our cardiovascular and oncology programs we are either conducting or are positioned to soon initiate proof of concept trials that we believe will inform potential registration paths for these novel drug candidates in their intended patient populations. Beginning with our cardiovascular program in September Cytokinetics presented two posters related to CK-452 at the 2007 Annual Heart Failure Society of America or HFSA meeting in Washington D.
IVR Clinical Concepts and mniComm Systems Inc. Announce Co-Marketing…
earthtimes.org – Oct 31, 2007
com) is a specialty company devoted todeveloping and implementing cost-effective Interactive Voice Responseapplications. Since its inception IVR Clinical Concepts has been dedicatedto providing real-time data and real-time reports for real-time results inclinical research for pharmaceuticals biotechnology and medical devicecompanies. IVR Clinical Concepts was formed in response to the desire inthe marketplace for a independent company that can develop and implementeffective and efficient solutions that are customized to each client andevery study. Clients who choose IVR Clinical Concepts for their InteractiveVoice Response solutions are rewarded with globally available applicationsthat put key decision-making information at their fingertips. About mniCommmniComm Systems Inc.
California-Based CR pens peration in Morrisville
WRAL.com – Oct 31, 2007
Synteract provides a variety of clinical trial services for life science companies. The Morrisville office will focus on clinical monitoring and site management safety surveillance and project management. Synteract is looking to hire safety associates clinical research associates project managers and sales management according to its Web site. “At Synteract responsive customer support is a promised standard that includes education mentoring and ongoing assistance” said Synteract’s Stewart Beiler senior vice president of Clinical perations and Project Management. “With these expanded operations capabilities we anticipate even faster growth than we have seen in the past few years. ” Copyright 2008 by Capitol Broadcasting Company. All rights reserved.
Q3 2007 Kforce Inc. Earnings Conference Call – Final.
Free with registration – Fair Disclosure Wire – AccessMyLibrary.com – Oct 31, 2007
26 was at consensus increasing operating leverage. nce again we established several new Firm records this quarter and we are approaching the end of year two of our three year plan and can see the fruit of the hard work of our teams. Hats off especially go to our clinical research team HIM Tech and KGH teams on another great quarter. ur focus is driving organic revenue growth and enhancing operating leverage. We hit a major milestone during the quarter with the implementation of our pay bill system in Q3 the culmination of years of effort and planning and we are grateful for the extraordinary effort of so many to accomplish this goal. We are excited about the enhanced capability our new technology platform will provide us in serving our customers. Uncertainty surrounding a cyclical slowdown remains and we are were frequently asked to comment on future economic trends.
Indian student develops molecular condom
सिफ॒ – सिफ॒ – Oct 31, 2007
<P>"This partnership will give the university a chance to place their technologies in the hands of people that need them most and will enhance the value of our technologies in the developed world" he said. <P>Apart from Pregna the university’s vice president of technology venture development Jack Brittain will also sign memoranda of understanding with Globerian Global Health Private Ltd. MediCity and Manipal AcuNova Ltd. <P>The memoranda to be signed in the presence of Utah Governor Jon Huntsman who is currently leading a trade delegation to India in Mumbai and New Delhi will initiate a long-term international collaboration between the University and India. <P>The university will work with each of the four companies to create a progressive alliance to accelerate commercialisation of university-invented technologies expand educational and research opportunities as well as aid in humanitarian efforts. <P>"These Indian companies are unique partners for the University of Utah" Brittain said. "Their leaders are innovative and eager to bring new medical technologies to their community.
Mice help chlamydia vaccine research
The Age – Oct 31, 2007
“There are antibiotics to treat chlamydia but there’s novaccine to prevent it” Prof Timms said. “In many cases women don’t know they are infected because thereare not really any physical signs or symptoms so by and large theydon’t get treatment. A report released by the National Centre in HIV Epidemiology andClinical Research earlier this month showed chlamydia notificationshad climbed from 41311 in 2005 to 47030 in 2006. Young people aged 15 to 24 are hardest hit accounting for morethan 60 per cent of all notifications so far this year.
rthopedic firms reveal payments in settlement
Minneapolis Star-Tribune – Minneapolis Star Tribune – Oct 31, 2007
Minnesota requires drugmakers to report all consulting payments made to doctors but no such requirement exists for medical device companies which are among the state’s largest and most lucrative employers. Medical device companies and many doctors say financial agreements with doctors are crucial to inventing and perfecting their products particularly in the evolving orthopedic field. In some cases doctors were involved in clinical research testing experimental devices. Richard Kyle a Minneapolis surgeon who is listed as receiving about $740000 from Zimmer and Smith & Nephew said the information required by the Justice Department is highly misleading. “It’s really unfair to lump everything together” he said. (nly Biomet lists services rendered for fees such as “education grant” and “clinical investigator.
Written by admin on October 31st, 2007 with
no comments.
Read more articles on News.